Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2021

Feb 24, 2021

1671_mrq_2021-02-24_6fdbac7b-1c0b-4c37-8e69-93e326c69c09.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1790Q

Societe Generale SA

24 February 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 23/02/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 797,465 0.62 1,734 0.00
(2) Derivatives (other than options) 1,428 0.00 8,131 0.01
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *2,307,521 *1.79 9,865 0.01

* Include the holding of shares 1,508,628 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 23 225.83
Purchase 115 225.17
Purchase 76 225.17
Purchase 76 225.17
Purchase 18 224.98
Purchase 16 224.1
Purchase 16 223.9
Purchase 21 226.07
Purchase 42 226.36
Purchase 35 226.36
Purchase 28 226.36
Purchase 42 226.36
Purchase 63 226.26
Purchase 84 226.28
Purchase 24 224.61
Purchase 26 224.4
Purchase 60 225.2
Purchase 12 224.63
Purchase 40 225.21
Purchase 19 224.285
Purchase 13 223.52
Purchase 25 224.98
Purchase 100 225.21
Purchase 20 224.26
Purchase 17 223.53
Purchase 29 224.93
Purchase 14 224.58
Purchase 28 225.25
Purchase 20 225.25
Purchase 10 224.14
Purchase 19 225.23
Purchase 31 225.16
Purchase 6 225.1
Purchase 100 226.36
Purchase 100 225.21
Purchase 1 225
Purchase 10 224.12
Purchase 92 224.57
Purchase 1 225
Purchase 97 225
Purchase 1 225.23
Purchase 21 225.21
Purchase 9 224.73
Purchase 1 225
Purchase 42 225.21
Purchase 100 225.21
Purchase 41 225.15
Purchase 17 224.73
Purchase 6 225.1
Purchase 24 224.61
Purchase 2,280 226.08
Purchase 1,368 226.08
Sale 26 225.14
Sale 74 225.14
Sale 916 226.08
Sale 16 226.08
Sale 1,237 226.08
Sale 1,976 226.08
Total Purchases 5,479
Total Sales 4,245

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 24/02/2021
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEKZLBLFLLBBBE